These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7295464)

  • 41. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
    Drew GM; Hilditch A; Levy GP
    Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 43. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P; Pozet N; Sassard J; Vincent M
    Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 47. I.v. labetalol in the treatment of hypertension following coronary-artery surgery.
    Morel DR; Forster A; Suter PM
    Br J Anaesth; 1982 Nov; 54(11):1191-6. PubMed ID: 7138722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of combined alpha- and beta-receptor blockade on peripheral circulation in essential hypertension.
    Heck I; Trübestein G; Stumpe KO
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():429s-432s. PubMed ID: 7318348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
    Hunyor SN; Bauer GE; Ross M; Larkin H
    Aust N Z J Med; 1980 Apr; 10(2):162-6. PubMed ID: 6930206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
    Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
    Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single dose of labetalol in hypertensive pregnancy: effects on maternal hemodynamics and uterine and fetal flow velocity waveforms.
    Pirhonen JP; Erkkola RU; Mäkinen JI; Ekblad UU
    J Perinat Med; 1991; 19(3):167-71. PubMed ID: 1748937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
    Michelson EL; Frishman WH
    Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-hypertensive action of labetalol: a detailed profile.
    Bellamy GR; Hunyor SN; Roffe D; Massang J
    Aust N Z J Med; 1982 Oct; 12(5):467-72. PubMed ID: 6758743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
    Rosei EA; Trust PM; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Sci Mol Med Suppl; 1976 Dec; 3():497s-499s. PubMed ID: 1071671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid reduction of blood pressure with acute oral labetalol.
    Davies AB; Bala Subramanian V; Gould B; Raftery EB
    Br J Clin Pharmacol; 1982 May; 13(5):705-10. PubMed ID: 7082539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.